CIDRAP newsletters options
COVID-19 patients visited their GPs 20% more often and clinics 10% more often.
CARB-X announced today that it is awarding Australian diagnostics company SpeeDx up to $1.8 million to develop a rapid molecular diagnostic test for chlamydia and gonorrhea infections.
Compared with non-pregnant women hospitalized with COVID-19, pregnant women with COVID-19 had lower in-hospital death rates, according to a research letter in the Annals of Internal Medicine today.
"We now have clear evidence that NSAIDs are safe to use in patients with COVID-19."
Also, India is reporting an increase in potentially deadly fungal lung infections.
The CDC says 44% of US adults are now fully vaccinated, as are 72% of seniors.
Use of infectious diseases (ID) telemedicine for management of Staphylococcus aureus bacteremia (SAB) at 10 US hospitals resulted in similar outcomes compared with on-site consultation, researchers reported today in Open Forum Infectious Diseases.
Mild COVID-19 infection was not linked to longer-term heart damage, according to a JACC Cardiovascular Imaging study late last week.
Israeli data show 92% effectiveness against asymptomatic COVID and 97% against symptomatic.
Also, India reports another daily record for deaths—4,197—along with 401,271 new cases.
While states are becoming optimistic, experts continue to advocate for aerosol-related mitigations.
Direct COVID-19 deaths may be more than double previous estimates, according to a report yesterday by the University of Washington's Institute for Health Metrics and Evaluation (IHME).
Data from a cohort of US acute care hospitals (ACHs) reveal an association between total and broad-spectrum antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) rates, researchers from the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Modeling from the CDC predicts the US will see a sharp drop in infections and deaths in the coming weeks.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
The vaccines show either effectiveness or a strong immune response against variants of concern.
Also, mixed reactions swirled on the proposed IP vaccine waiver, and more Asian nations took steps to battle COVID-19.
The AstraZeneca-Oxford COVID-19 vaccine is associated with some increases in bleeding and clotting events, according to a BMJ study yesterday, but experts say the benefits outweigh the risks.
Saudi Arabia's Ministry of Health (MOH) today reported a new MERS-CoV case, which involves a 36-year-old man who died from his infection.
The man was from Hafr Al-Batin in the country's northeast. An investigation found that the man had been exposed to camels. He wasn't a healthcare worker and isn't thought to have contracted MERS-CoV (Middle East respiratory syndrome coronavirus) from another person.
